Status:
COMPLETED
Medical and Serological Follow-up of the Staff of the Paris Saint-Joseph Hospital Group Infected With Severe Acute Respiratory Syndrome Coronavirus 2.
Lead Sponsor:
Fondation Hôpital Saint-Joseph
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Coronavirus SARS CoV-2 (COVID-19) pandemic is causing a major global health crisis that is disrupting our hospital organizations and creating potential infectious risks for hospital staff on the f...
Detailed Description
This institutional process had been validated by senior management and staff representative bodies. It was based on voluntary work, anonymity, the confidential aspect of the employees' analyses with t...
Eligibility Criteria
Inclusion
- employee aged over 18 years
- employee who participated to the serology tests
- employee who was tested positively to the Covid-19 serology test
- French speaking employee
- employee affiliated to a French social security or any other health insurance system.
- employee who is able to give its free and written consent.
Exclusion
- employee under guardianship or curatorship
- employee deprived of liberty
- employee under the protection of justice.
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 23 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04488484
Start Date
July 1 2020
End Date
May 23 2022
Last Update
April 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Groupe Hospitalier Paris Saint-Joseph
Paris, France, 75014